Optimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection. Hew J, Mohtashami A, Mastrocostas K, Skinner T, et al. Int J Colorectal Dis 2026;41:50.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hew J, Mohtashami A, Mastrocostas K, Skinner T, et al. Optimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection. Int J Colorectal Dis 2026;41:50.
PMID: 41612034